CD44 and neoplasm: Another study also showed that recombinant PRG4 expression led to the tumor suppression by inhibiting transforming growth factor beta (TGFβ) which led to the decreased hyaluronan (HA)-cell surface cluster of differentiation 44 (CD44)33.